Abstract
Idiopathic thrombocytopenic purpura (ITP) in children is a heterogeneous disease from the point of view of its natural course and pattern of treatment response. Even in uncomplicated ITP, there is a large variation in disease presentation and prognosis. Although in children it is usually a self limited disorder [1], chronicity (evolution longer than 6 months) and life-threatening bleeds are the main challenges of patients with ITP, justifying preoccupations for their prediction and prevention [2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
